Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$2.48B |
| 2 |
Wells Fargo
WFC
|
+$2.4B |
| 3 |
NVIDIA
NVDA
|
+$2.03B |
| 4 |
American Express
AXP
|
+$948M |
| 5 |
Amazon
AMZN
|
+$855M |
Top Sells
| 1 |
Pfizer
PFE
|
+$1.71B |
| 2 |
Chubb
CB
|
+$1.57B |
| 3 |
ConocoPhillips
COP
|
+$1.49B |
| 4 |
Microsoft
MSFT
|
+$1.37B |
| 5 |
Advanced Micro Devices
AMD
|
+$1.15B |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 20.37% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Praxis Precision Medicines
PRAX
$843M
| $2.41M | ﹤0.01% |
+39,565
| New | +$2.41M |
|
|
FINV
1402
FinVolution Group
FINV
$1.98B
| $2.4M | ﹤0.01% |
477,094
| – | – |
|
1403
Mersana Therapeutics
MRSN
$38.2M
| $2.4M | ﹤0.01% |
+21,385
| New | +$2.4M |
|
1404
Y-mAbs Therapeutics
YMAB
$390M
| $2.38M | ﹤0.01% |
+146,303
| New | +$2.38M |
|
|
DCPH
1405
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.37M | ﹤0.01% |
150,873
+102,327
| +211% | +$1.61M |
|
1406
Phathom Pharmaceuticals
PHAT
$914M
| $2.37M | ﹤0.01% |
223,390
+68,999
| +45% | +$733K |
|
1407
Universal Health Services
UHS
$11.9B
| $2.35M | ﹤0.01% |
12,859
-250
| -2% | -$45.6K |
|
1408
Expedia Group
EXPE
$26.9B
| $2.34M | ﹤0.01% |
17,019
+12,973
| +321% | +$1.79M |
|
1409
WEC Energy
WEC
$34.6B
| $2.33M | ﹤0.01% |
28,432
-2,924
| -9% | -$240K |
|
1410
News Corp Class A
NWSA
$16.6B
| $2.33M | ﹤0.01% |
88,973
+78,544
| +753% | +$2.06M |
|
1411
Henry Schein
HSIC
$8.2B
| $2.3M | ﹤0.01% |
30,420
-1,601
| -5% | -$121K |
|
1412
Caribou Biosciences
CRBU
$171M
| $2.27M | ﹤0.01% |
441,806
+127,726
| +41% | +$657K |
|
1413
Bank of America Series L
BAC.PRL
$3.91B
| $2.26M | ﹤0.01% |
1,897
-3,126
| -62% | -$3.73M |
|
1414
Old Republic International
ORI
$9.97B
| $2.26M | ﹤0.01% |
73,628
| – | – |
|
1415
Hershey
HSY
$38B
| $2.24M | ﹤0.01% |
11,525
-7,726
| -40% | -$1.5M |
|
1416
Liquidia Corp
LQDA
$2.39B
| $2.24M | ﹤0.01% |
151,965
+81,427
| +115% | +$1.2M |
|
1417
iShares China Large-Cap ETF
FXI
$6.83B
| $2.24M | ﹤0.01% |
93,121
-2,961
| -3% | -$71.3K |
|
1418
Snap-on
SNA
$16.8B
| $2.23M | ﹤0.01% |
7,521
-151,712
| -95% | -$44.9M |
|
1419
Brookfield Renewable
BEPC
$6.09B
| $2.21M | ﹤0.01% |
90,133
-176,660
| -66% | -$4.34M |
|
1420
Roblox
RBLX
$91.4B
| $2.2M | ﹤0.01% |
57,674
+16,772
| +41% | +$640K |
|
1421
Sonoco
SON
$4.51B
| $2.2M | ﹤0.01% |
37,986
-1,491
| -4% | -$86.2K |
|
1422
Accuray
ARAY
$180M
| $2.18M | ﹤0.01% |
884,079
-937,200
| -51% | -$2.31M |
|
1423
US Bancorp
USB
$76.8B
| $2.15M | ﹤0.01% |
48,139
+4,812
| +11% | +$215K |
|
1424
West Pharmaceutical
WST
$18.1B
| $2.15M | ﹤0.01% |
5,421
-416
| -7% | -$165K |
|
1425
Knowles
KN
$1.83B
| $2.15M | ﹤0.01% |
+133,238
| New | +$2.15M |
|